| 000 | 01614 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517174848.0 | ||
| 264 | 0 | _c20190320 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155217731507 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoyd, A M | |
| 245 | 0 | 0 |
_aRisk factors for cefepime nonsusceptible Gram-negative infections in allogeneic hematopoietic cell transplant recipients. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cMar 2019 |
||
| 300 |
_a279-288 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCefepime _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xetiology |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aPerissinotti, A J | |
| 700 | 1 | _aNagel, J L | |
| 700 | 1 | _aFrame, D G | |
| 700 | 1 | _aMarini, B L | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 25 _gno. 2 _gp. 279-288 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155217731507 _zAvailable from publisher's website |
| 999 |
_c27604908 _d27604908 |
||